EOLS
Evolus Inc

3,853
Mkt Cap
$280.67M
Volume
744,165.00
52W High
$14.94
52W Low
$4.09
PE Ratio
-4.75
EOLS Fundamentals
Price
$4.30
Prev Close
$4.33
Open
$4.31
50D MA
$5.55
Beta
1.05
Avg. Volume
1.52M
EPS (Annual)
-$0.813
P/B
-9.75
Rev/Employee
$802,030.12
$727.69
Loading...
Loading...
News
all
press releases
Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Evolus (EOLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·16h ago
News Placeholder
More News
News Placeholder
Evolus (EOLS) Expected to Announce Earnings on Tuesday
Evolus (NASDAQ:EOLS) will be releasing its Q4 2025 earnings after the market closes on Tuesday, March 3. (View Earnings Report at...
MarketBeat·20h ago
News Placeholder
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its fourth quarter and full-year 2025...
Business Wire·8d ago
News Placeholder
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today reported the grant during December 2025, January 2026, and February 2026 of an...
Business Wire·11d ago
News Placeholder
Evolus, Inc. (NASDAQ:EOLS) Given Average Rating of "Moderate Buy" by Brokerages
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. One...
MarketBeat·20d ago
News Placeholder
What is HC Wainwright's Forecast for Evolus FY2026 Earnings?
Evolus, Inc. (NASDAQ:EOLS - Free Report) - Stock analysts at HC Wainwright cut their FY2026 earnings estimates for shares of Evolus in a research note issued to investors on Tuesday, February 3rd. HC...
MarketBeat·20d ago
News Placeholder
Boston Scientific (BSX) Beats Q4 Earnings and Revenue Estimates
Boston Scientific (BSX) delivered earnings and revenue surprises of +2.96% and +0.39%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
HC Wainwright Lowers Evolus (NASDAQ:EOLS) Price Target to $13.00
HC Wainwright reduced their price objective on Evolus from $20.00 to $13.00 and set a "buy" rating on the stock in a research note on Tuesday...
MarketBeat·22d ago
News Placeholder
Evolus (NASDAQ:EOLS) Given New $13.00 Price Target at BTIG Research
BTIG Research cut their target price on Evolus from $18.00 to $13.00 and set a "buy" rating on the stock in a research note on Thursday...
MarketBeat·1mo ago
News Placeholder
David Moatazedi Sells 10,539 Shares of Evolus (NASDAQ:EOLS) Stock
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) insider David Moatazedi sold 10,539 shares of the firm's stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average...
MarketBeat·2mo ago
<
1
2
...
>

Latest EOLS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.